193 related articles for article (PubMed ID: 33187811)
1. When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities.
Wang Q; Berger NA; Xu R
Blood Rev; 2021 May; 47():100775. PubMed ID: 33187811
[TBL] [Abstract][Full Text] [Related]
2. Nationwide analysis of adult hospitalizations with hematologic malignancies and systemic sclerosis.
Romero Noboa ME; Litvin R; Sami F; Tanveer S
ARP Rheumatol; 2023; 2(4):291-298. PubMed ID: 38174748
[TBL] [Abstract][Full Text] [Related]
3. Changes in mortality associated with different hematologic malignancies during the pandemic in the United States.
Fedeli U; Barbiellini Amidei C; Han X; Jemal A
Int J Cancer; 2024 May; 154(10):1703-1708. PubMed ID: 38335457
[TBL] [Abstract][Full Text] [Related]
4. Disparities in the Outcomes of Acute Pulmonary Embolism in Hospitalized Patients with Hematologic Malignancy and Solid Tumor.
Hou J; Qiu Z; Yu L; Wen S; Zheng L
Int Heart J; 2023; 64(3):432-441. PubMed ID: 37258119
[TBL] [Abstract][Full Text] [Related]
5. [The Risk and Survival Analysis of Multiple Malignancies in Hematologic Malignancy Patients: A Single Chinese Center Retrospective Study, 2009 through 2017].
Zhang XC; Fan L; Lu H; Qian SX; Chen LJ; Xu W; Li JY; Qu XY; Zhao XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):389-395. PubMed ID: 37096510
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Infection and Severity in Patients with Hematologic Malignancies: A Systematic Review.
SeyedAlinaghi S; Karimi A; Mirzapour P; Salmani R; Razi A; Mojdeganlou H; Mojdeganlou P; Qodrati M; Jashaninejad R; Paranjkhoo P; Dadras O; Zarezadeh B; Afsahi AM; Afzalian A; Varshochi S; Mehraeen E; Afsahi G
Infect Disord Drug Targets; 2023; 23(7):29-38. PubMed ID: 37138433
[TBL] [Abstract][Full Text] [Related]
7. Mortality and clinical outcomes following SARS-CoV-2 infection among individuals with haematological malignancies: A Danish population-based cohort study.
Lund LC; Rahbek MT; Brown P; Obel N; Hallas J; Frederiksen H
Eur J Haematol; 2023 Dec; 111(6):946-950. PubMed ID: 37740535
[TBL] [Abstract][Full Text] [Related]
8. Impact of Social Disparities on 5-Year Survival Rates in Pediatric Hematologic Malignancies.
Chalfant V; Riveros C; Bechtel A; Bradfield SM; Stec AA
J Pediatr Hematol Oncol; 2024 Jan; 46(1):33-38. PubMed ID: 37910818
[TBL] [Abstract][Full Text] [Related]
9. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.
Lahmer T; Salmanton-García J; Marchesi F; El-Ashwah S; Nucci M; Besson C; Itri F; Jaksic O; Čolović N; Weinbergerová B; Seval GC; Adžić-Vukičević T; Szotkowski T; Sili U; Dargenio M; van Praet J; van Doesum J; Schönlein M; Ráčil Z; Žák P; Poulsen CB; Magliano G; Jiménez M; Bonuomo V; Piukovics K; Dragonetti G; Demirkan F; Blennow O; Valković T; Gomes Da Silva M; Maertens J; Glenthøj A; Fernández N; Bergantim R; Verga L; Petzer V; Omrani AS; Méndez GA; Machado M; Ledoux MP; Bailén R; Duarte RF; Del Principe MI; Farina F; Martín-Pérez S; Dávila-Valls J; Marchetti M; Bilgin YM; Fracchiolla NS; Cattaneo C; Espigado I; Cordoba R; Collins GP; Labrador J; Falces-Romero I; Prezioso L; Meers S; Passamonti F; Buquicchio C; López-García A; Kulasekararaj A; Ormazabal-Vélez I; Cuccaro A; Garcia-Vidal C; Busca A; Navrátil M; de Jonge N; Biernat MM; Guidetti A; Abu-Zeinah G; Samarkos M; Anastasopoulou A; de Ramón C; González-López TJ; Hoenigl M; Finizio O; Pinczés LI; Ali N; Vena A; Tascini C; Stojanoski Z; Merelli M; Emarah Z; Kohn M; Barać A; Mladenović M; Mišković B; Ilhan O; Çolak GM; Čerňan M; Gräfe SK; Ammatuna E; Hanakova M; Víšek B; Cabirta A; Nordlander A; Nunes Rodrigues R; Hersby DS; Zambrotta GPM; Wolf D; Núñez-Martín-Buitrago L; Arellano E; Aiello TF; García-Sanz R; Prattes J; Egger M; Limongelli A; Bavastro M; Cvetanoski M; Dibos M; Rasch S; Rahimli L; Cornely OA; Pagano L;
Infection; 2024 Jun; 52(3):1125-1141. PubMed ID: 38388854
[No Abstract] [Full Text] [Related]
10. Clinical characteristics and outcomes of COVID-19 infection in Chinese patients with hematologic malignancies in the Omicron era.
Li X; Zhao A; Jiang H; Lu Y; Le J; Xie Y; Hu M; Zeng H; Zhao J; Zhou M; Zhou H; Chen L; Zhu W; Ouyang G; Qiu H; Jiang S; Guo Q; Qian W; Liang Y
Hematology; 2023 Dec; 28(1):2288477. PubMed ID: 38038062
[TBL] [Abstract][Full Text] [Related]
11. Disparity in hematological malignancies: From patients to health care professionals.
Chen X; Shukla M; Saint Fleur-Lominy S
Blood Rev; 2024 May; 65():101169. PubMed ID: 38220565
[TBL] [Abstract][Full Text] [Related]
12. A Scoping Review of Otologic Manifestations of Hematologic Malignancies.
Raymond MJ; Ottinger A; Rowley MA; Bobian M; Dornhoffer J; Brennan E; Rizk HG
Otol Neurotol; 2024 Apr; 45(4):362-375. PubMed ID: 38437804
[TBL] [Abstract][Full Text] [Related]
13. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Chari A; Samur MK; Martinez-Lopez J; Cook G; Biran N; Yong K; Hungria V; Engelhardt M; Gay F; García Feria A; Oliva S; Oostvogels R; Gozzetti A; Rosenbaum C; Kumar S; Stadtmauer EA; Einsele H; Beksac M; Weisel K; Anderson KC; Mateos MV; Moreau P; San-Miguel J; Munshi NC; Avet-Loiseau H
Blood; 2020 Dec; 136(26):3033-3040. PubMed ID: 33367546
[TBL] [Abstract][Full Text] [Related]
14. Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited.
Ribas A; Sengupta R; Locke T; Zaidi SK; Campbell KM; Carethers JM; Jaffee EM; Wherry EJ; Soria JC; D'Souza G;
Cancer Discov; 2021 Feb; 11(2):233-236. PubMed ID: 33355178
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 infection in children, adolescents, and young adults with Down syndrome and hematologic malignancies.
Foxworthy B; Dai C; Davis EC; Xavier AC; Brackett J; Dickens D; Kahn A; Martinez I; Sharma A; Schwalm C; Foley J; Wilkes J; ; Bhatia S; Levine JM; Johnston EE; Wolfson JA
Pediatr Blood Cancer; 2024 May; ():e31082. PubMed ID: 38804869
[TBL] [Abstract][Full Text] [Related]
16. [Adherence to treatment of hematological malignancies patients with anxiety and depression].
Vybornykh DE; Moiseeva TN; Gemdzhian EG; Gaponova TV; Esina LV; Kolgaeva EI; Novikova DV
Ter Arkh; 2023 Sep; 95(7):554-559. PubMed ID: 38159005
[TBL] [Abstract][Full Text] [Related]
17. Mobile Source Benzene Regulations and Risk of Childhood and Young Adult Hematologic Cancers in Alaska: A Quasi-experimental Study.
Nethery RC; Vega S; Frazier AL; Laden F
Epidemiology; 2023 May; 34(3):385-388. PubMed ID: 36715968
[TBL] [Abstract][Full Text] [Related]
18. Cancer-associated thrombosis in hematologic malignancies.
Fukatsu M; Ikezoe T
Int J Hematol; 2024 May; 119(5):516-525. PubMed ID: 38270784
[TBL] [Abstract][Full Text] [Related]
19. The relationship between hematologic malignancies on male hypogonadism: a scoping review.
Roth B; Moukhtar Hammad MA; Sanford DI; Piper M; Barham DW; Yafi FA; Jenkins LC
Sex Med Rev; 2024 Mar; ():. PubMed ID: 38515317
[TBL] [Abstract][Full Text] [Related]
20. Management of Patients With Hematologic Malignancies During the COVID-19 Pandemic: Practical Considerations and Lessons to Be Learned.
Isidori A; de Leval L; Gergis U; Musto P; Porcu P
Front Oncol; 2020; 10():1439. PubMed ID: 32923397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
